menu search

Small-cap biotech opportunity knocks

Among the most beaten-down assets in the first month of 2022 were biotechnology stocks, with smaller members of that group enduring significant punish...

February 1, 2022, 12:29 pm

Small-cap biotech opportunity knocks

Among the most beaten-down assets in the first month of 2022 were biotechnology stocks, with smaller members of that group enduring significant punish...

February 1, 2022, 12:29 pm

Small-cap biotech opportunity knocks

Among the most beaten-down assets in the first month of 2022 were biotechnology stocks, with smaller members of that group enduring significant punish...

February 1, 2022, 12:29 pm

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfo...

February 1, 2022, 9:59 am

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfo...

February 1, 2022, 9:59 am

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfo...

February 1, 2022, 9:59 am

3 biotech stocks that could boom or bust in q1

The biotech industry is exploding. biotech stocks provid...

February 1, 2022, 6:00 am

3 biotech stocks that could boom or bust in q1

The biotech industry is exploding. biotech stocks provid...

February 1, 2022, 6:00 am

3 biotech stocks that could boom or bust in q1

The biotech industry is exploding. biotech stocks provid...

February 1, 2022, 6:00 am

biotech rallies, but is still on track for its third worst month ever

Oppenheimer's Jared Holz has four biotech stocks to bet on, after the sector's third worst month ever. ...

January 31, 2022, 6:54 pm

biotech rallies, but is still on track for its third worst month ever

Oppenheimer's Jared Holz has four biotech stocks to bet on, after the sector's third worst month ever. ...

January 31, 2022, 6:54 pm

biotech rallies, but is still on track for its third worst month ever

Oppenheimer's Jared Holz has four biotech stocks to bet on, after the sector's third worst month ever. ...

January 31, 2022, 6:54 pm

Celyad oncology announces february 2022 conference schedule

MONT-SAINT-GUIBERT, Belgium, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...

January 31, 2022, 4:05 pm

Celyad oncology announces february 2022 conference schedule

MONT-SAINT-GUIBERT, Belgium, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...

January 31, 2022, 4:05 pm

Celyad oncology announces february 2022 conference schedule

MONT-SAINT-GUIBERT, Belgium, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...

January 31, 2022, 4:05 pm

How to invest in biotech when deep value has no discernible meaning

Biotech's blue bloods are the best bets in the space right now....

January 31, 2022, 10:00 am

How to invest in biotech when deep value has no discernible meaning

Biotech's blue bloods are the best bets in the space right now....

January 31, 2022, 10:00 am

How to invest in biotech when deep value has no discernible meaning

Biotech's blue bloods are the best bets in the space right now....

January 31, 2022, 10:00 am

Arcellx sets ipo terms, looks to raise up to $140.3 million

Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer treatm...

January 31, 2022, 8:30 am

Arcellx sets ipo terms, looks to raise up to $140.3 million

Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer treatm...

January 31, 2022, 8:30 am


Search within

Pages Search Results: